Accessbio Rapid Antigen Test
RAPID POC TEST
Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.
As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.
Lateral flow assay
Rapid results in 10 minutes
Minimally invasive specimen collection (nasopharyngeal)
Intended at POC setting (i.e., in patient care settings) by medical professionals
Detect SARS-CoV-2 nucleocapsid protein antigen
Identify acute infection with high sensitivity and 100% specificity
Currently In stock
Inquire About This Product
RAPID POC TEST
Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.
As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.
Lateral flow assay
Rapid results in 10 minutes
Minimally invasive specimen collection (nasopharyngeal)
Intended at POC setting (i.e., in patient care settings) by medical professionals
Detect SARS-CoV-2 nucleocapsid protein antigen
Identify acute infection with high sensitivity and 100% specificity
Currently In stock
Inquire About This Product
RAPID POC TEST
Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.
As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.
Lateral flow assay
Rapid results in 10 minutes
Minimally invasive specimen collection (nasopharyngeal)
Intended at POC setting (i.e., in patient care settings) by medical professionals
Detect SARS-CoV-2 nucleocapsid protein antigen
Identify acute infection with high sensitivity and 100% specificity
Currently In stock
